CCL2 and myeloid sarcoma: For each group, i.e. control subjects, MS patients without hippocampal lesions, MS patients with active/chronic active hippocampal lesions and MS patients with inactive hippocampal lesions, the mean and standard deviation of CCL2 and CCR2 positive cell numbers per ROI per case are summarized in Table 5.